HEALTHWAY MEDICAL CORPORATION LIMITED - Key Persons
Job Titles:
- Non - Independent Non - Executive Director
Dr Khor Chin Kee was appointed as a Non-Independent Non-Executive Director of the Company on 1 July 2022. He is also a Medical Consultant/Advisor to FWD Singapore since 1 June 2018 where he advises on medical related insurance matters.
As Co-founding Partner of Healthway Medical Corporation Limited in 1990, Dr Khor went on to hold the role of CEO in United Vision Holdings Pte Ltd, AsiaMedic Ltd and Parkway Shenton, before returning to Healthway Medical Corporation Limited to serve as Senior Medical Advisor and subsequently as CEO from 1 June 2018 until his retirement as CEO and appointment as a Non-Independent Non-Executive Director of the Company on 1 July 2022.
Dr Khor holds a Bachelor of Medicine and a Bachelor of Surgery from the National University of Singapore.
Job Titles:
- Non - Independent Non - Executive Director
- Executive Chairman of OUE Limited
Dr Stephen Riady was appointed as a Non-Independent Non-Executive Director of the Company on 16 August 2017 and was re-appointed on 26 April 2021. He is a deemed controlling shareholder of the Company. Details of his deemed shareholdings can be found on pages 67 and 139 to 141 of the Annual Report.
Dr Riady was appointed as Executive Chairman of OUE Limited on 9 March 2010. He has been serving as Executive Director of OUE Limited since 30 November 2006, and as its Group Chief Executive Officer (in an expansion of his role as Executive Chairman) from 1 January 2020. OUE Limited is listed on the Mainboard of the Singapore Exchange Securities Trading Limited ("SGX-ST"). Dr Riady is also an Executive Director of Lippo Limited and has been its Chairman since 1991. He was appointed as a Director of Lippo China Resources Limited and Hongkong Chinese Limited in 1992 and in March 2011 respectively, and was appointed as Chairman of both companies in 2011. Dr Riady is currently the Executive President of Lippo Limited, Lippo China Resources Limited and Hongkong Chinese Limited, all of which are listed on the Main Board of The Stock Exchange of Hong Kong. Dr Riady is also a member of the Remuneration Committee and Nomination Committee of Lippo Limited, Lippo China Resources Limited and Hongkong Chinese Limited respectively.
His service to society includes civic engagements such as founding honorary advisor of the University of Hong Kong Foundation for Education Development and Research, member of the Boards of Trustees of Volunteer Service Trust and The Better Hong Kong Foundation, member of the Advisory Council of One Country, Two Systems Research Institute, fellow of the Duke of Edinburgh's Award World Fellowship and member of the Advisory Board of Sloan School of Management of the Massachusetts Institute of Technology, United States of America. Dr Riady also holds the positions of Trustee of the Global Board of Trustees of Asia Society; Executive Vice President, China Federation of Overseas Chinese Entrepreneurs; and Permanent Honorary Chairman, Singapore Research Centre of Institute for Global Development of Tsinghua University.
In public service, Dr Riady was a Hong Kong Affairs Advisor from April 1995 to June 1997, appointed by the Hong Kong and Macao Office of the State Council and Xinhua News Agency, Hong Kong Branch of the People's Republic of China ("PRC"). In addition, he is a member of the Committee to Promote Economic Co-operation between Fujian and Hong Kong, a committee established by the Provincial Government of Fujian, PRC.
Among his accolades are the Chevalier de L'Ordre des Arts et des Lettres awarded by the French government, and the Strategic Investment Entrepreneur of the Year in Ernst & Young's annual Entrepreneur of the Year Awards Singapore 2007. Dr Riady was awarded the 2018 EY Asean Entrepreneurial Excellence Award, an award which recognises successful Southeast Asia businesses that contribute to the economy and community in the region. He is an Honorary Citizen of Shenzhen, PRC.
Dr Riady holds a Bachelor of Science, Business Administration from the University of Southern California, United States of America and a Master of Business Administration from Golden Gate University, United States of America. He was conferred an Honorary Degree of Doctor of Business Administration from Edinburgh Napier University, United Kingdom, and is one of the first Honorary University Fellows installed by the Hong Kong Baptist University.
Job Titles:
- Executive Director
- Executive Vice Chairman
Mr Abram Melkyzedeck Suhardiman was re-designated as the Executive Vice Chairman of Healthway Medical Corporation Limited on 9 March 2023 from his prior position as the Executive Director of Healthway Medical Corporation Limited and Deputy CEO of the Group.
Mr Abram Melkyzedeck Suhardiman was appointed as the Executive Director of the Company on 26 April 2019 and was re-designated from Chief Operating Officer to Deputy Chief Executive Officer ("Deputy CEO") of the Company and its subsidiaries (the "Group") on 10 February 2020. Mr Suhardiman was re-designated to the position of Executive Vice Chairman on 9 March 2023. He was last re-appointed on 27 April 2022 as an Executive Director of the Company.
Prior to joining Healthway Medical Corporation Limited, Mr Suhardiman served as the Vice President at Nuvest Capital, Singapore. He has also worked at The Abraaj Group and Citibank where he was part of the investment team in Southeast Asia. Mr Suhardiman holds a Bachelor of Science in Business Administration from the University of Southern California, Los Angeles, United States of America and a Masters in Finance from Hult International Business School, San Francisco, United States of America.
Job Titles:
- Non - Independent Non - Executive Director
Mr Anand Kumar was appointed as a Non-Independent Non-Executive Director of the Company on 24 March 2017 and was last re-appointed on 26 April 2021. He is the Co-Founder and Partner of Gateway Partners, an investment firm focused on growth capital and strategic opportunities across markets in Southeast Asia, South Asia, the Middle East and Africa.
Mr Kumar has over 30 years of experience in Investments, Mergers & Acquisitions, Equity Capital Markets and Leveraged Finance in Southeast Asia with a strong network of relationships in the region. Prior to co-founding Gateway Partners in 2014, Mr Kumar held leadership positions in several leading investment banks including Standard Chartered Bank and Morgan Stanley.
He is a Non-Executive Director of TVS Supply Chain Solutions Limited (India) and Land Registration System Inc (Philippines); Nominee Director of Medall Healthcare Private Limited; member of the Board of Commissioners of PT Lippo Karawaci Tbk (Indonesia) and PT Lippo Cikarang Tbk (Indonesia); as well as an Independent Director of Tube Investments of India Limited and Cholamandalam Investment and Finance Company Limited.
Mr Kumar holds a Master of Business Administration degree from Vanderbilt University, United States of America.
Job Titles:
- Lead Independent Director
- Managing Director of One Partnership
Mr Chen Yeow Sin was appointed as Lead Independent Director of the Company on 21 July 2017 and was last re-appointed on 6 July 2020. He is the Chairman of the Audit and Risk Committee and the Nominating Committee and a member of the Remuneration Committee.
Mr Chen is the Managing Director of One Partnership, a public accounting corporation that provides audit, tax and business advisory services, where he oversees the firm's operation, risk management and growth strategy. In addition to that, he also heads its Risk Advisory division, providing internal audit and enterprise risk management services to listed companies with operations in both Singapore and the Asian region. Mr Chen started his accountancy and audit training with a firm of chartered accountant in London. Upon his qualification as a chartered accountant, he worked in 2 of the Big Four accounting firms in Singapore before joining a US Fortune 500 energy and resource company as its South East Asia regional internal audit manager where he was responsible for risks management, internal controls and conflict of interest investigation.
Mr Chen holds a Bachelor of Science (Honours) degree from University of London and is a Fellow Singapore Chartered Accountant as well as a Fellow Chartered Accountants in England and Wales.
Job Titles:
- Vice President, Communications
- Vice President, Communications and Doctor Engagement
Mr Jordan Isac is the Vice President, Communications and Doctor Engagement at Healthway Medical Corporation Limited.
He is also part of the Chairman's Office, OUE Limited, where he has been involved in various real estate development projects, including OUE Twin Peaks, OUE Downtown and US Bank Tower. Prior to this, Mr Isac served in the Ministry of Foreign Affairs, Singapore, where he covered political developments in the ASEAN and South Asia Directorates.
Mr Isac holds a double bachelor's degree from the University of Melbourne, Master in Political Science from the University of Oxford and an Executive Master of Business Administration from Peking University and University of Pelita Harapan.
Job Titles:
- Vice President
- Vice President, Projects and Quality Assurance
Mr Louis Poey is the Vice President, Projects and Quality Assurance at Healthway Medical Corporation Limited.
Mr Ong Hon Yuh is the Chief Operating Officer of Healthway Medical Corporation Limited with effect from 9 March 2023. Mr Ong has had more than 10 years of experience in healthcare and has led corporate functions and clinical units spanning strategy, planning and operations functions. Prior to joining Heathway Medical Corporation Limited, Mr Ong served as the Vice President at IHH Healthcare. He was most recently the Director of Operations at Parkway Laboratory Services after serving as Assistant Vice President ("AVP") at Gleneagles Hospital while concurrently holding the post of AVP, Corporate Planning for IHH Singapore.
Before joining private healthcare, Mr Ong was with National University Health System and National University Hospital where he served as the head of various departments in Corporate Planning, Strategic Planning Office and at the National University Cancer Institute Singapore. Prior to healthcare, Mr Ong worked at OCBC and Standard Chartered Bank after he ended active service with the Singapore Armed Forces.
Mr Ong holds a Bachelor's in Economics from London School of Economics and Masters in Finance from Imperial College on a Singapore Armed Forces scholarship. He completed the Stanford Executive Programme at the Stanford University Graduate School of Business in 2022.
Mr Sachin Sheth is the Chief Financial Officer of Healthway Medical Corporation Limited. Besides assisting the CEO on strategic initiatives and Mergers & Acquisitions ("M&A"), Mr Sheth is responsible for overseeing the Group's overall finance, compliance, corporate governance, accounting, legal, corporate secretarial and taxation functions.
Prior to joining Healthway Medical Corporation Limited, Mr Sheth worked at Adcorp Holdings (Singapore) Pte Limited as Chief Financial Officer for Adcorp Group's international business across Australia, Singapore and the rest of Africa. He has more than 25 years of cross-border international experience in the field of finance, banking, M&A, accounting, auditing and taxation and has held several senior roles with local and international companies covering Asia-Pacific, Africa and the European region.
Mr Sheth holds a Chartered Accountant qualification from the Institute of Chartered Accountants of India and a Bachelor of Commerce from Gujarat University, India.
Mr Sin Boon Ann was appointed as an Independent Chairman of the Company on 26 April 2019 and was last re-appointed on 27 April 2022. He is the Chairman of the Remuneration Committee, and a member of the Audit and Risk Committee and the Nominating Committee.
Mr Sin holds a Bachelor of Arts and a Bachelor of Laws (Honours) from the National University of Singapore in 1982 and 1986 respectively, and a Master of Laws from the University of London in 1988. He was admitted to the Singapore Bar in 1987, and was a member of the teaching staff of the law faculty in National University of Singapore from 1987 to 1992 prior to his career with Drew & Napier LLC.
Currently, Mr Sin is a Consultant with Drew & Napier LLC. He joined Drew & Napier LLC in 1992, with focus on corporate finance and mergers & acquisitions. He was the Deputy Managing Director of the Corporate & Finance Department and the Co-head of the Capital Markets Practice in Drew & Napier LLC before he retired in March 2018.
Mr Sin is recognized in industry publications as an industry leader and for his expertise in capital markets. He was a Member of Parliament for Tampines Group Representation Constituency (GRC) from 1996 to 2011.
Mr Sin was conferred the Singapore National Day Award - "The Public Service Star (Bintang Bakti Masyarakat)" in 2018 and "The Public Service Medal (Pingat Bakti Masyarakat)" in 2013 by the President of Singapore and received the NTUC May Day Award - "Distinguished Service Award" in 2018, "Meritorious Service Award" in 2013 and "Friends of Labour Award" in 2003 for his invaluable contributions and commitment to the labour movement in Singapore.
Mr Stephens Lo is the Chief Executive Officer ("CEO") of Healthway Medical Corporation Limited. Mr Lo is responsible for leading the organisation's growth strategy and overseeing the Group's operations.
Most recently, Mr Lo was Chief Strategy Officer at Smarter Health Pte Ltd, a health-tech start up in Singapore. Prior to that, Mr Lo spent 13 years at IHH Healthcare Group where he served as Chief Executive Officer and Chief Operating Officer at their flagship hospitals in Singapore; Mount Elizabeth Hospital, Mount Elizabeth Novena Hospitals and Gleneagles Hospital. Mr Lo also spent 3 years in Vietnam where he was Chief Executive Officer of City International Hospital in Ho Chi Minh City.
Mr Lo holds a Bachelor's in Economics and Accounting from the University of Bristol, United Kingdom and a Masters in Accounting and Finance from London School of Economics, United Kingdom.
Ms Aliza Knox was appointed as an Independent Director of the Company on 6 November 2020 and was last re-appointed on 26 April 2021. She is also an Independent Director of Tyro Payments Limited and a senior advisor to the Boston Consulting Group. She previously served on the boards of several listed companies including Singapore Post Limited, Scentre Group (Westfield), Australia and Grant Thornton International, United Kingdom, and as an Independent Director and a Technology Advisor to the Technology Subcommittee of the Board of ANZ Bank, Australia.
Ms Knox was the Head of Asia Pacific ("APAC") of Cloudflare, Pte. Ltd., and was the Vice President of APAC for Twitter Asia Pacific Pte. Ltd., prior to that, having joined the digital enterprise after building a significant business for Google in APAC.
Ms Knox was named the IT Woman of the Year (APAC) 2020, AWA Singapore International Business Woman of the Year in 2015, elected as Chief Executive Women (Australia) in 2016, and featured in the 2018 book, "Women on Board - Making a Real Difference". She led SWAT (Super Women at Twitter) and did the same for Women@Google. She has served on two key committees for the Singapore Government, namely, she was appointed by the Ministry of Education, Singapore, to the Committee to review University Education Pathways Beyond 2030 as well as appointed by the Singapore Government Committee to review the Future of Work, Play, Live, which was linked to its #SmartNation initiative. Ms Knox is also a contributing columnist at Forbes.
Ms Knox has significant financial services and international experience. Her prior roles included Senior Vice-President ("SVP"), Commercial Solutions, Visa International; SVP, International, Charles Schwab; and Partner and Head of Financial Services at Boston Consulting Group in Sydney and Singapore.
Ms Knox graduated magna cum laude, Phi Beta Kappa with a Bachelor of Arts in Applied Math and Economics from Brown University, United States of America, and holds a Master of Business Administration with Distinction in Marketing from The New York University Leonard N. Stern School of Business, United States of America.